Safety, Tolerability and Clinical Activity of ASM-024 in Stable Moderate Asthma

NCT01190826 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: ASM-024
DRUG: ASM-024 100 mg
DRUG: Placebo

Sponsor

Asmacure Ltée